We are all familiar with the PSA screening test for prostate cancer, and the CEA test for colo-rectal cancer. What is unique about the AMAS test, is its reported ability to detect virtually all types of cancers. Today, when trying to detect cancer in its early stages, your doctor may perform a physical examination and a variety of laboratory tests including chest x-ray, sigmoidoscopy, CT scans, mammograms, pap tests, prostate biopsies, to name a few. Tomorrow, these tests may be unnecessary unless the AMAS is abnormal. The AMAS test may prove to be the most sensitive way of determining whether or not a particular cancer treatment program has been curative or not.
Research demonstrates that when cancer surgery has been curative, the AMAS value returns to normal.
Should any cancer remain, the AMAS test will remain elevated. This will allow oncologists the ability to recommend further cancer treatment only for those patients who need it, and avoid over treating those who do not. The usefulness of the AMAS test to determine if a cancer has been cured has perhaps been best studied in breast cancer. To date, over 1,000 breast cancer patients have been followed with the AMAS test. Results show convincingly that breast cancer cannot be presumed to be in remission unless the AMAS levels are in the normal range.